These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 22658894)
41. Increased expression of fibroblastic growth factor receptor 2 is correlated with poor prognosis in patients with breast cancer. Sun S; Jiang Y; Zhang G; Song H; Zhang X; Zhang Y; Liang X; Sun Q; Pang D J Surg Oncol; 2012 Jun; 105(8):773-9. PubMed ID: 22006548 [TBL] [Abstract][Full Text] [Related]
42. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer. Grönberg M; Fjällskog ML; Jirström K; Janson ET Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021 [TBL] [Abstract][Full Text] [Related]
43. High expression of Sirt7 served as a predictor of adverse outcome in breast cancer. Geng Q; Peng H; Chen F; Luo R; Li R Int J Clin Exp Pathol; 2015; 8(2):1938-45. PubMed ID: 25973086 [TBL] [Abstract][Full Text] [Related]
44. Increased expression of mitotic arrest deficient-like 1 (MAD1L1) is associated with poor prognosis and insensitive to Taxol treatment in breast cancer. Sun Q; Zhang X; Liu T; Liu X; Geng J; He X; Liu Y; Pang D Breast Cancer Res Treat; 2013 Jul; 140(2):323-30. PubMed ID: 23860928 [TBL] [Abstract][Full Text] [Related]
45. [Expression of translationally controlled tumor protein in human breast cancer and its clinical significance]. Li SJ; Jia HY; Wu D; Fan ZM Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1560-3. PubMed ID: 21945766 [TBL] [Abstract][Full Text] [Related]
46. Breast cancer cell motility is promoted by 14-3-3γ. Hiraoka E; Mimae T; Ito M; Kadoya T; Miyata Y; Ito A; Okada M Breast Cancer; 2019 Sep; 26(5):581-593. PubMed ID: 30830684 [TBL] [Abstract][Full Text] [Related]
47. Expression and clinicopathological significance of FSIP1 in breast cancer. Zhang H; Luo M; Jin Z; Wang D; Sun M; Zhao X; Zhao Z; Lei H; Li M; Liu C Oncotarget; 2015 Apr; 6(12):10658-66. PubMed ID: 25826084 [TBL] [Abstract][Full Text] [Related]
48. p53 suppresses 14-3-3γ by stimulating proteasome-mediated 14-3-3γ protein degradation. Chen DY; Dai DF; Hua Y; Qi WQ Int J Oncol; 2015 Feb; 46(2):818-24. PubMed ID: 25384678 [TBL] [Abstract][Full Text] [Related]
49. Emerging roles of 14-3-3γ in the brain disorder. Cho E; Park JY BMB Rep; 2020 Nov; 53(10):500-511. PubMed ID: 32958119 [TBL] [Abstract][Full Text] [Related]
50. Deubiquitinating enzyme USP37 regulating oncogenic function of 14-3-3γ. Kim JO; Kim SR; Lim KH; Kim JH; Ajjappala B; Lee HJ; Choi JI; Baek KH Oncotarget; 2015 Nov; 6(34):36551-76. PubMed ID: 26427597 [TBL] [Abstract][Full Text] [Related]
51. Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer. Shi Q; Liu T; Zhang X; Geng J; He X; Nu M; Pang D Oncol Lett; 2016 Oct; 12(4):2606-2612. PubMed ID: 27698834 [TBL] [Abstract][Full Text] [Related]
52. Correlation between the expression of Rap1GTPase activating protein and the clinicopathological features of invasive breast cancer. Jin CM; Gong FY; Gui JQ; Li RH; Wang YY; Xu CY; Lin Y; Liu HF J Biol Regul Homeost Agents; 2019 September-October,; 33(5):1485-1491. PubMed ID: 31496205 [No Abstract] [Full Text] [Related]
53. 14-3-3γ Haploinsufficient Mice Display Hyperactive and Stress-sensitive Behaviors. Kim DE; Cho CH; Sim KM; Kwon O; Hwang EM; Kim HW; Park JY Exp Neurobiol; 2019 Feb; 28(1):43-53. PubMed ID: 30853823 [TBL] [Abstract][Full Text] [Related]
54. The role of the 14-3-3 protein family in health, disease, and drug development. Aghazadeh Y; Papadopoulos V Drug Discov Today; 2016 Feb; 21(2):278-87. PubMed ID: 26456530 [TBL] [Abstract][Full Text] [Related]
55. Identification of 14-3-3γ as a Mieap-interacting protein and its role in mitochondrial quality control. Miyamoto T; Kitamura N; Ono M; Nakamura Y; Yoshida M; Kamino H; Murai R; Yamada T; Arakawa H Sci Rep; 2012; 2():379. PubMed ID: 22532927 [TBL] [Abstract][Full Text] [Related]
56. Reciprocity in breast cancer progression. Gespach C Oncotarget; 2014 Nov; 5(22):10967-8. PubMed ID: 25526025 [No Abstract] [Full Text] [Related]
57. Arnicolide C Suppresses Tumor Progression by Targeting 14-3-3θ in Breast Cancer. Liu Z; Lyu X; Chen J; Zhang B; Xie S; Yuan Y; Sun L; Yuan S; Yu H; Ding J; Yang M Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399439 [No Abstract] [Full Text] [Related]
58. 14-3-3η Promotes Invadosome Formation via the FOXO3-Snail Axis in Rheumatoid Arthritis Fibroblast-like Synoviocytes. Kadiri M; Charbonneau M; Lalanne C; Harper K; Balg F; Marotta A; Dubois CM Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008549 [TBL] [Abstract][Full Text] [Related]
59. Regulation of breast cancer metastasis signaling by miRNAs. Petri BJ; Klinge CM Cancer Metastasis Rev; 2020 Sep; 39(3):837-886. PubMed ID: 32577859 [TBL] [Abstract][Full Text] [Related]
60. The induction of endoreduplication and polyploidy by elevated expression of 14-3-3γ. Gomes CJ; Centuori SM; Harman MW; Putnam CW; Wolgemuth CW; Martinez JD Genes Cancer; 2017 Nov; 8(11-12):771-783. PubMed ID: 29321819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]